Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research

posted on October 18, 2019
 Dr. Joaquim Trias, Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson's Research, last October 13th Sunday in San Mateo. The run was organized by The Michel J. Fox Foundation, a prestigious organization launched in year 2000 by the iconic actor Michael J.…
continue reading →

SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

posted on July 24, 2019
As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to…
continue reading →

SOM Biotech attended 3rd “Hard Reg Café” meeting dedicated to the topic of FDA approval for new drugs

posted on July 23, 2019
Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory Affairs meeting that took place on June 5 at the Barcelona Science Park (www.pcb.ub.edu). The event was organized by the CataloniaBio & HealthTech Regulatory Affairs Workgroup with the support of ACCIÓ (Government of Catalonia). The main objective of the meeting…
continue reading →

SOM Biotech collaborated in the organization of the University of Barcelona Summer Course about Rare Diseases

posted on July 18, 2019
SOM Biotech collaborated in the organization of the University of Barcelona Summer Course: "Rare Diseases: from the patient to the cure". Within the framework of the course, Dr. Raúl Insa, SOM Biotech CEO, did a master class included in the module “Pharmaceuticals in rare diseases”. The topic of his speech was: "Repositioning of drugs in…
continue reading →

SOM Biotech participated at Barcelona Biotech Breakfast: Applying Artificial Intelligence in Drug Discovery and Development

posted on July 10, 2019
Oscar Huertas, Drug Discovery Manager, and Maria Zimina, Business Development Manager of SOM Biotech, participated at DIT Barcelona Biotech Breakfast: Applying AI in Drug Discovery and Development. The event took place at the Parc Cientific de Barcelona on 19th of June 2019. The event included masterclasses in an open panel discussion format with leading British and Catalan speakers…
continue reading →

SOM Biotech at Veeva R&D Summit Europe 2019

posted on June 13, 2019
Dr. Raúl Insa, SOM Biotech CEO, participated in the Clinical Roundtable at Veeva R&D Summit Europe 2019.  The clinical team of SOM Biotech: Dr. Santiago Esteva and Aileen Ferré, attended the conference sessions organized in the framework of the Summit. The Summit took place in Barcelona last 11-13 June 2019. Veeva R&D Summit Europe is…
continue reading →